028300.KQ HLB | KR7028300002
Company Profile
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. Additionally, it develops biological drugs with MoA to infectious diseases. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.
Latest News
Oil prices dip over 6% after US, Iran pause fighting over weekend
Reuters • 07/27/2026
Fractus and Geotab settle U.S. patent litigation
PR Newswire • 07/27/2026
Starcore Reports Year End 2026 Results
TMX Newsfile • 07/27/2026
Tredence Launches Domain Native Forward Deployed Engineering to Close the Last Mile of Enterprise AI
PR Newswire • 07/27/2026
Earnings To Watch: Corning (GLW) Reports Q2 Results Tomorrow
StockStory • 07/27/2026
| Sector | Healthcare |
| Industry | Biotechnology |
| Website | https://www.hlbbio.co.kr/ |
| Audit Risk | 1 |
| Board Risk | 6 |
| Overall Risk | 7 |
| Market Cap | 4.15T |
| Enterprise-to-Revenue | 52.24 |
| Enterprise-to-EBITDA | -50.58 |
| Earnings Date | |
| Earnings Call Date |